AAAAAA

   
Results: 1-8 |
Results: 8
Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants
Authors: Struyf, S Stoops, G Van Coillie, E Gouwy, M Schutyser, E Lenaerts, JP Fiten, P Van Aelst, I Proost, P Opdenakker, G Van Damme, J
Citation: S. Struyf et al., Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants, BIOCHEM, 40(39), 2001, pp. 11715-11722
PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia
Authors: Nelissen, I Fiten, P Vandenbroeck, K Hillert, J Olsson, T Marrosu, MG Opdenakker, G
Citation: I. Nelissen et al., PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia, J NEUROIMM, 108(1-2), 2000, pp. 153-159
Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis
Authors: Nelissen, I Vandenbroeck, K Fiten, P Hillert, J Olsson, T Marrosu, MG Opdenakker, G
Citation: I. Nelissen et al., Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis, J NEUROIMM, 105(1), 2000, pp. 58-63
Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene
Authors: Andrei, G Snoeck, R De Clercq, E Esnouf, R Fiten, P Opdenakker, G
Citation: G. Andrei et al., Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene, J GEN VIROL, 81, 2000, pp. 639-648
Monitoring drug resistance for herpesviruses
Authors: Andrei, G Fiten, P De Clercq, E Snoeck, R Opdenakker, G
Citation: G. Andrei et al., Monitoring drug resistance for herpesviruses, METH MOL M, 24, 2000, pp. 151-169
Analysis of an IFN-gamma gene (IFNG) polymorphism in multiple sclerosis inEurope: Effect of population structure on association with disease
Authors: Goris, A Epplen, C Fiten, P Andersson, M Murru, R Sciacca, FL Ronsse, I Jackel, S Epplen, JT Marrosu, MG Olsson, T Grimaldi, LME Opdenakker, G Billiau, A Vandenbroeck, K
Citation: A. Goris et al., Analysis of an IFN-gamma gene (IFNG) polymorphism in multiple sclerosis inEurope: Effect of population structure on association with disease, J INTERF CY, 19(9), 1999, pp. 1037-1046
Transcriptional control of the human MCP-2 gene promoter by IFN-gamma and IL-1 beta in connective tissue cells
Authors: Van Coillie, E Van Aelst, I Fiten, P Billiau, A Van Damme, J Opdenakker, G
Citation: E. Van Coillie et al., Transcriptional control of the human MCP-2 gene promoter by IFN-gamma and IL-1 beta in connective tissue cells, J LEUK BIOL, 66(3), 1999, pp. 502-511
Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development
Authors: Fiten, P Vandenbroeck, K Dubois, B Van Coillie, E Nelissen, I Van Damme, J Ligers, A Hillert, J Andersson, M Olsson, T Opdenakker, G
Citation: P. Fiten et al., Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development, J NEUROIMM, 95(1-2), 1999, pp. 195-201
Risultati: 1-8 |